APTINYX INC's ticker is APTX and the CUSIP is 03836N103. A total of 44 filers reported holding APTINYX INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $6 | -25.0% | 46,312 | +70.9% | 0.00% | – |
Q4 2022 | $8 | -99.7% | 27,095 | +369.4% | 0.00% | – |
Q2 2022 | $3,000 | -70.0% | 5,772 | +28.5% | 0.00% | – |
Q1 2022 | $10,000 | -74.4% | 4,493 | -69.3% | 0.00% | -100.0% |
Q4 2021 | $39,000 | +129.4% | 14,633 | +105.7% | 0.00% | – |
Q3 2021 | $17,000 | – | 7,115 | +237066.7% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 3 | -100.0% | 0.00% | -100.0% |
Q1 2021 | $35,000 | +59.1% | 11,383 | +78.2% | 0.00% | 0.0% |
Q4 2020 | $22,000 | -72.5% | 6,388 | -73.0% | 0.00% | 0.0% |
Q3 2020 | $80,000 | -13.0% | 23,643 | +7.6% | 0.00% | -75.0% |
Q2 2020 | $92,000 | +1740.0% | 21,978 | +894.5% | 0.00% | – |
Q1 2020 | $5,000 | -61.5% | 2,210 | -41.0% | 0.00% | -100.0% |
Q4 2019 | $13,000 | -82.7% | 3,743 | -82.6% | 0.00% | -80.0% |
Q3 2019 | $75,000 | +368.8% | 21,450 | +360.4% | 0.01% | +400.0% |
Q2 2019 | $16,000 | -40.7% | 4,659 | -29.8% | 0.00% | -50.0% |
Q1 2019 | $27,000 | -25.0% | 6,633 | +204.0% | 0.00% | -33.3% |
Q4 2018 | $36,000 | – | 2,182 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 3,290,079 | $1,836,000 | 1.19% |
ADAMS STREET PARTNERS LLC | 5,395,996 | $3,010,000 | 0.78% |
Bain Capital Life Sciences Investors, LLC | 8,891,758 | $4,961,000 | 0.58% |
Artal Group S.A. | 6,116,493 | $3,412,000 | 0.18% |
Frazier Life Sciences Management, L.P. | 1,883,244 | $1,051,000 | 0.10% |
NORTHWESTERN UNIVERSITY | 109,280 | $61,000 | 0.06% |
DCF Advisers, LLC | 48,529 | $27,000 | 0.02% |
Meridian Wealth Management, LLC | 192,000 | $107,000 | 0.01% |
Orbimed Advisors | 538,500 | $300,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 157,641 | $88,000 | 0.00% |